KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifeward (LFWD) EBITDA (2016 - 2025)

Lifeward's EBITDA history spans 11 years, with the latest figure at -$3.1 million for Q3 2025.

  • For Q3 2025, EBITDA rose 1.07% year-over-year to -$3.1 million; the TTM value through Sep 2025 reached -$29.8 million, down 47.04%, while the annual FY2024 figure was -$29.3 million, 24.29% down from the prior year.
  • EBITDA for Q3 2025 was -$3.1 million at Lifeward, up from -$6.6 million in the prior quarter.
  • Across five years, EBITDA topped out at -$2.7 million in Q3 2021 and bottomed at -$15.2 million in Q4 2024.
  • The 5-year median for EBITDA is -$4.4 million (2024), against an average of -$5.2 million.
  • The largest YoY upside for EBITDA was 60.04% in 2024 against a maximum downside of 148.13% in 2024.
  • A 5-year view of EBITDA shows it stood at -$3.8 million in 2021, then tumbled by 30.64% to -$5.0 million in 2022, then dropped by 22.62% to -$6.1 million in 2023, then tumbled by 148.13% to -$15.2 million in 2024, then surged by 79.38% to -$3.1 million in 2025.
  • Per Business Quant, the three most recent readings for LFWD's EBITDA are -$3.1 million (Q3 2025), -$6.6 million (Q2 2025), and -$4.9 million (Q1 2025).